Advertisement
Research Article

Regulating Factors of PrPres Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains

  • Etienne Levavasseur,

    Affiliation: INSERM, Avenir Team - Human Prion Diseases, Paris, France

    X
  • Isabelle Laffont-Proust,

    Affiliation: INSERM, Avenir Team - Human Prion Diseases, Paris, France

    X
  • Émilie Morain,

    Affiliation: INSERM, Avenir Team - Human Prion Diseases, Paris, France

    X
  • Baptiste A. Faucheux,

    Affiliations: INSERM, Avenir Team - Human Prion Diseases, Paris, France, APHP, R. Escourolle Neuropathology Laboratory, Paris, France

    X
  • Nicolas Privat,

    Affiliation: INSERM, Avenir Team - Human Prion Diseases, Paris, France

    X
  • Katell Peoc'h,

    Affiliation: Biochemistry and Molecular Biology Department, Lariboisière Hospital, Paris, France

    X
  • Véronique Sazdovitch,

    Affiliations: INSERM, Avenir Team - Human Prion Diseases, Paris, France, APHP, R. Escourolle Neuropathology Laboratory, Paris, France

    X
  • Jean-Philippe Brandel,

    Affiliation: INSERM, Avenir Team - Human Prion Diseases, Paris, France

    X
  • Jean-Jacques Hauw,

    Affiliations: APHP, R. Escourolle Neuropathology Laboratory, Paris, France, InVS, French National Center of Reference for Unconventional Transmissible Agents, Paris, France

    X
  • Stéphane Haïk mail

    haik@chups.jussieu.fr

    Affiliations: INSERM, Avenir Team - Human Prion Diseases, Paris, France, APHP, R. Escourolle Neuropathology Laboratory, Paris, France, InVS, French National Center of Reference for Unconventional Transmissible Agents, Paris, France

    X
  • Published: July 30, 2008
  • DOI: 10.1371/journal.pone.0002786

Reader Comments (0)

Post a new comment on this article